Letter Sequence Approval |
|---|
|
Results
Other: ML20338A160, ML20338A165, ML21026A001, ML21055A810, ML21055A820, ML21110A147, ML21110A148, ML21159A143, ML21187A126, ML21204A101, ML21309A105, ML22109A121, ML22200A061, ML22259A001, ML24040A176, ML24040A179, ML24044A062, ML24044A063
|
MONTHYEARML19221B7422019-08-30030 August 2019 Proprietary Determination Letter for ANP-10337, Revision 0, Supplement 1P, Revision 0, Deformable Spacer Grid Element RAI Response Project stage: RAI ML19347C1932019-12-10010 December 2019 Email Transmittal of Request for Additional Information Questions Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: RAI ML20083K3862020-03-26026 March 2020 Round 1 Request for Additional Information Questions for the Review of Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Non-Proprietary) Project stage: RAI ML20338A1652020-12-10010 December 2020 Regulatory Audit Plan for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 Project stage: Other ML20338A1602020-12-10010 December 2020 December 7 - 11, 2020, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21026A0012021-02-0909 February 2021 Audit Report Letter for Framatome Topical Report ANP-10229P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21055A8102021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021 Regulatory Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 EPID L-2018-TOP-0034 Project stage: Other ML21055A8202021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021, Regulatory Audit Plan Letter for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21110A1472021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L-2018-TOP-0034) (Letter) Project stage: Other ML21110A1482021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21159A1432021-06-11011 June 2021 June 15, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21187A1262021-07-0909 July 2021 July 9, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21204A1012021-07-27027 July 2021 August 11-12, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - ARTEMIS-RELAP Integrated Transient Analysis Methodology Project stage: Other ML21309A1052021-11-0808 November 2021 November 8, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22109A1212022-04-22022 April 2022 April 20 - 21, and 28, 2022, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22097A2642022-04-26026 April 2022 U.S. Nuclear Regulatory Commissions Revised Schedule for Review of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML22200A0612022-07-25025 July 2022 Report for 2021 - 2022, Regulatory Audits Regarding Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22259A0012022-10-0505 October 2022 Schedule Change Letter for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22357A0822023-01-0909 January 2023 The U.S. Nuclear Regulatory Commissions Revised Schedule for the Review of Framatome’S Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML23006A2522023-01-17017 January 2023 Summary of Closed Hybrid Meeting with Framatome Inc. and the U. S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230079, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-01-30030 January 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23072A3862023-04-0606 April 2023 Summary of March 2, 3023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, ANP-10339P, Revision 0, ARITA-ARTEMIS/RELAP Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230725, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-06-0909 June 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23177A2582023-07-10010 July 2023 Summary of June 20, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20231147, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-10-0606 October 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23233A1392023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L 2018-TOP-0034) Letter Project stage: Approval ML23299A2402023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Appendix IV) - Non-Proprietary Project stage: Approval ML23299A2322023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology - Non-Proprietary Project stage: Approval ML23305A0642023-11-0505 November 2023 Summary of October 19, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting ML24044A0632024-02-13013 February 2024 Transmittal Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24044A0622024-02-13013 February 2024 Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24040A1792024-04-16016 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Topical Report Project stage: Other ML24040A1762024-04-22022 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Transmittal (EPID L-2018-TOP-0034) - Email Project stage: Other 2022-04-26
[Table View] |
Text
January 9, 2023 Mr. Gary Peters, Director Licensing and Regulatory Affairs Framatome Inc.
3315 Old Forest Road Lynchburg, VA 24501
SUBJECT:
THE U.S. NUCLEAR REGULATORY COMMISSIONS REVISED SCHEDULE FOR THE REVIEW OF FRAMATOMES TOPICAL REPORT, ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY (EPID L-2018-TOP-0034)
Dear Mr. Peters:
The U.S. Nuclear Regulatory Commission (NRC) staff plans to revise the schedule for its review of Framatome, Inc. (Framatome) Topical Report (TR) ANP-10339P, Revision 0, ARITA - ARTEMIS/RELAP Integrated Transient Analysis Methodology (ARITA)
(Agencywide Documents Access and Management System (ADAMS) Package Accession No. ML18242A480), submitted on August 28, 2018. By letters dated April 26, 2022 (ADAMS Accession No. ML22097A264), and October 5, 2022 (ADAMS Accession No. ML22259A001),
the NRC staff revised the ANP-10339P, Revision 0, review schedule.
Due to the complexity of the review of TR ANP-10339P, Revision 0, and resource challenges, the NRC staff plans to revise the current ANP-10339P, Revision 0, review schedule. This revised review schedule provides a new baseline for the TR ANP-10339P, Revision 0. The NRC staff plans to issue the draft safety evaluation (SE) by March 31, 2023, and final SE by June 30, 2023, as annotated in the enclosed revised schedule. Therefore, the Advisory Committee on Reactor Safeguards subcommittee and full committee meetings will be rescheduled to May 19, 2023, and June 7, 2023, respectively.
Additionally, the NRC staff plans to provide the final list of limitations and conditions (L&Cs) to Framatome by February 24, 2023, and would be ready to have discussions during closed/open meetings or audits before the L&Cs are finalized. The NRC staff plans to finalize the list of L&Cs in the draft SE by March 10, 2023.
If you have any questions regarding the TR review, please contact me at 301-415-6695 or via email at Ngola.Otto@nrc.gov.
Sincerely,
/RA/
Ngola A. Otto, Project Manager Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket No.: 99902041
Enclosure:
As stated
Enclosure U.S. NUCLEAR REGULATORY COMMISSION REVISED REVIEW SCHEDULE FOR THE FRAMATOME, INC.
TOPICAL REPORT ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY DOCKET NO. 99902041 EPID L-2018-TOP-0034 Milestone Current Date Revised Date U.S. Nuclear Regulatory Commission (NRC)
Issues Draft Safety Evaluation (SE)
January 16, 2023 March 31, 2023 Advisory Committee on Reactor Safeguards (ACRS) Subcommittee Meeting February 16, 2023 May 19, 2023 ACRS Full Committee Meeting March 2, 2023 June 7, 2023 NRC Issues Final SE March 31, 2023 June 30, 2023
G. Peters
SUBJECT:
THE U.S. NUCLEAR REGULATORY COMMISSIONS REVISED SCHEDULE FOR THE REVIEW OF FRAMATOMES TOPICAL REPORT, ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY (EPID L-2018-TOP-0034)
DATED: JANUARY 9, 2023 JLehning, NRR JKaizer, NRR JEvans, NRR SKrepel, NRR NOtto, NRR JDonoghue, NRR MJRoss-Lee, NRR GSuber, NRR BPham, NRR DISTRIBUTION:
PUBLIC RidsACRS_MailCTR Resource RidsNrrLADHarrison Resource RidsOgcMailCenter Resource RidsNrrDorl Resource RidsNrrDssSfnb Resource RidsNrrDorlLlpb Resource RidsResOd Resource RidsNrrDss Resource KHeller, NRR ADAMS Accession Number: ML22357A082
- via email OFFICE NRR/DORL/LLPB/PM* NRR/DORL/LLPB/LA* NRR/DSS/SFNB/BC* NRR/DORL/LLPB/ Acting BC*
NAME NOtto DHarrison SKrepel CRosales-Cooper DATE 12/23/2022 01/06/2023 01/06/2023 01/09/2023 OFFICE NRR/DORL/LLPB/PM*
NAME NOtto DATE 01/09/2023 OFFICIAL RECORD COPY